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Abstract
Background In Australia, around 59% of the general population uses prescription medi-
cation with this number increasing to about 86% in those aged 65 and over and 83% of the
population over 85 using two or more medications simultaneously. A recent report suggests
that between 2% and 3% of all hospital admissions in Australia may be medication related
with older Australians at higher risk because of higher levels of medicine intake and increased
likelihood of being admitted to hospital. The most common medication errors encountered
in hospitals in Australia are prescription/medication ordering errors, dispensing, administra-
tion and medication recording errors. Contributing factors to these errors have largely not
been reported in the hospital environment. In the community, inappropriate drugs, prescrib-
ing errors, administration errors, and inappropriate dose errors are most common.
Objectives To present the best available evidence for strategies to prevent or reduce the
incidence of medication errors associated with the prescribing, dispensing and administra-
tion of medicines in the older persons in the acute, subacute and residential care settings,
with specific attention to persons aged 65 years and over.
Search strategy Bibliographic databases PubMed, Embase, Current contents, The
Cochrane Library and others were searched from 1986 to present along with existing health
technology websites. The reference lists of included studies and reviews were searched for
any additional literature.
Selection criteria Systematic reviews, randomised controlled trials and other research
methods such as non-randomised controlled trials, longitudinal studies, cohort or case–
control studies, or descriptive studies that evaluate strategies to identify and manage
medication incidents. Those people who are involved in the prescribing, dispensing or
administering of medication to the older persons (aged 65 years and older) in the acute,
subacute or residential care settings were included. Where these studies were limited,
evidence available on the general patient population was used.
Data collection and analysis Study design and quality were tabulated and relative
risks, odds ratios, mean differences and associated 95% confidence intervals were calcu-
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lated from individual comparative studies containing count data where possible. All
other data were presented in a narrative summary.
Results Strategies that have some evidence for reducing medication incidents are:
• computerised physician ordering entry systems combined with clinical decision
support systems;
• individual medication supply systems when compared with other dispensing
systems such as ward stock approaches;
• use of clinical pharmacists in the inpatient setting;
• checking of medication orders by two nurses before dispensing medication;
• a Medication Administration Review and Safety committee; and
• providing bedside glucose monitors and educating nurses on importance of
timely insulin administration.
In general, the evidence for the effectiveness of intervention strategies to reduce
the incidence of medication errors is weak and high-quality controlled trials are
needed in all areas of medication prescription and delivery.
Key words: intervention studies, medication errors, nursing, prevention.
Introduction
Background
In Australia, around 59% of the general population uses
prescription medication with this number increasing to
about 86% in those aged 65 and over, and with 83% of the
population over 85 using two or more medications
simultaneously.1
A recent report suggests that between 2% and 3% of all
hospital admissions in Australia may be medication related.2
The Harvard Medical Practice study in the USA found that
in hospital patients disabled by some form of medical
treatment, 19% of recorded adverse events were related to
medications.3
Older Australians have higher rates of medication incidents
because of higher levels of medicine intake and increased
likelihood of being admitted to hospital (hospital statistics
being the main source of medication incident reporting).4
In the community setting, it has been estimated that up
to 400 000 adverse drug events may be managed in general
practices each year in Australia.4
The financial burden is staggering with one estimate put-
ting the cost of preventable medication errors in the USA
alone between $17 and $29 billion per year.5 In Australia,
the cost has been estimated at over $350 million annually.2
What are the types and causes of medication errors?
Studies examining the types and causes of medication errors
occurring in older adults (≥65 years) are limited. However,
evidence is available on the general population and is taken
to be representative of those issues that would arise in the
geriatric setting. Where specific reference to older adults is
found, it is highlighted in this report.
In a recent review by the Australian Council for Safety and
Quality in Health Care, the types of medication errors most
frequently encountered in an Australian healthcare setting
and their likely causes were presented.4 The results of this
report present the best data with a particular focus on Aus-
tralia that is presently available and are summarised as
follows.
Errors in hospital. The most common errors related to
medication that are encountered in hospitals in Australia are:
• prescription/medication ordering errors;
• dispensing errors;
• errors in administration of medicines; and
• errors in the medication record.
Table 1 Types of medication errors in general medical practice
Type of incident Rate per 100 incidents
Inappropriate drug 30
Prescribing error 22
Administration error 18
Inappropriate dose 15
Side-effect 13
Allergic reaction 11
Dispensing error 10
Overdose 8
System inadequacies 7
Drug omitted or withheld 6
Source: Australian Council for Safety and Quality in Health Care (2002, 
p. 33).4
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Data from the Australian Incident Monitoring System
showed that most medication incidents occurring in hospital
were categorised as omissions (>25%), overdoses (20%),
wrong medicines (10%), drug of addiction discrepancy
(<5%), incorrect labelling (<5%) or an adverse drug reaction
(<5%). However, little is known as to why medication errors
occur in Australian hospitals. Failure to read, or misreading
the chart, and a lack of robust systems for prescribing and
ordering were suggested as the reasons for most of these
errors.4
Errors can occur at any step in the medication process. A
recent Australian review has attempted to describe the types
of medication errors at each stage in the process, which is
summarised as follows.4
Prescription/medication  ordering  errors.  Medication
errors occur during the prescribing or interpretation/trans-
lation of orders from one document to another.
Based on limited Australian data on prescription errors,
approximately 2% of all prescriptions have the potential to
cause an adverse event with the most common causes being
the wrong or ambiguous dose, missing dose, or the direc-
tions for use were unclear or absent. This can be compared
with other countries in which the medication error rates
have been reported to be between 2% and 7%.6
Dispensing errors. Dispensing errors occurring within the
hospital pharmacy have not been comprehensively studied.
Error rates have been reported to range from 0.08% to 0.8%
of all items dispensed. However, the causes and the potential
for adverse events have not been reported.4
Errors in administration of medicines. These errors occur
when different patient medication supply systems are used.
When patients are given medicines from a common ward
supply, error rates are between 15% and 20% compared
with error rates of between 5% and 8% when individual
patient medicine supplies are provided.4
Timing errors as high as 8% of administered doses have
been shown to occur as a result of a patient being provided
with a medicine at least 1 h before or 1 h after the scheduled
time. These errors occur most likely because of time con-
straints and are unlikely to cause harm in the majority of
cases.4
Errors in the medication record. A common error is the
lack of documentation of previous adverse drug reactions and
allergies. Australian studies have found that previously known
adverse drug reactions were not recorded in 75–77% of cases
evaluated. In another study 8% of cases had omissions of
known allergic reactions in patient records. The causes and
potential for adverse drug events were not described.4
Errors in the community setting. The review described
medication incidents in general practice and community
pharmacies.4 General practitioners (GPs) and pharmacists
were asked to provide explanation as to why the medication
incidents occurred.
General practice. The types of medication incidents most
commonly reported are described in Table 1. The factors
contributing to these errors are summarised in Table 2. 
Pharmacies. The most common types of dispensing errors
reported by pharmacists are the selection of the incorrect
strength, incorrect product or misinterpretation of a pre-
scription. The major reason for selecting the incorrect
strength or product has been described as the result of ‘look
alike’ or ‘sound alike’ error.
The report4 describes an Australian survey of 209 commu-
nity pharmacists where the major factors cited for contrib-
uting to dispensing errors were cited as:
• high prescription volume;
• overwork;
• fatigue;
• interruptions to dispensing; and
• ‘look alike, sound alike’ drug names.
Other factors that contribute to medication errors. The
review also described other possible factors that could con-
tribute to medication error.4
Inadequate continuity of care. Medication histories upon
admission or discharge from hospital are often incomplete.
Studies reviewing discharge prescriptions for patients found
that 15% of medications intended to be continued were
Table 2 Factors contributing to incidents in general practice
Contributing factor Rate per
100 incidents
Poor communication between patient and health 
professionals
23
Action of others (not general practitioner or 
patient)
23
Error of judgement 22
Poor communication between health professionals 19
Patient consulted other medical officer 15
Failure to recognise signs and symptoms 15
Patient’s history not adequately reviewed 13
Omission of checking procedure 10
General practitioner tired, rushed or running late 10
Patient misunderstood their problem and/or 
treatment
10
Inadequate patient assessment 10
No correlation between these contributing factors and the resulting incident 
(Table 1) was made.
Source: Australian Council for Safety and Quality in Health Care (2002, 
p. 33).4
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omitted at discharge, or that at least one medicine on aver-
age was omitted from the discharge prescription. At admis-
sion one study found that on average one medicine was not
documented on the medication history for every two
patients.
In one survey of 106 GPs regarding the type of informa-
tion they received from hospital about their patients, no
notification was provided to the GPs in over 50% of cases.
Because of a change in patient medications by the hospital
in 87% of cases, the patient’s medicine at discharge was
different from what the GP understood before admission in
72% of cases.
Finally, in a regional hospital in Queensland, of the referral
medical records of 100 oncology patients, 72% had the
potential for one or more errors in the patient’s medication.
The most common reasons for these errors were described as:
• insufficient documentation to allow dosages to be
confirmed;
• handwritten or illegible medication orders; and
• lack of instruction about the length of time between
cycles of chemotherapy.
Multiple healthcare providers. In one study of 204 peo-
ple, 48% had medicines prescribed by more than one doc-
tor and 28% had medicines dispensed by more than one
pharmacist. The effect on medication error and adverse drug
events has not been studied.
Keeping unnecessary medications. This involves keeping
medications that are no longer in use or have passed their
expiry date. In one small study where pharmacists made
home visits to assist in medication management, 21% of
people were keeping medicines that were no longer in use
and 20% were keeping expired medications. The effect on
medication error and adverse drug events has not been
studied.
Generic names/trade names. One study found that 29%
of consumers did not understand the difference between
the generic and trade name of a medication. Again, the
effect on medication error and adverse drug events has not
been studied.
Understanding the label. In a single survey 84% ‘older
consumers’ incorrectly interpreted the instruction to ‘take
one tablet every 6 h, 1 h before food’. The effect on medi-
cation error and adverse drug events has not been studied.
As medication errors can occur at all stages in the medi-
cation process, from prescription by physicians to delivery
of medication to the patient by nurses, and in any site in
the health system, it is essential that interventions be tar-
geted at all aspects of medication delivery.4
Therefore, it is vital that healthcare providers be aware of
the current evidence in relation to effective interventions for
reducing the incidence of medication errors. This review
attempts to summarise the best available evidence on these
research interventions highlighting where possible, preven-
tion in the aged care arena.
Objectives
To present the best available evidence for strategies to pre-
vent or reduce the incidence of medication errors associated
with the prescribing, dispensing and administration of med-
icines in the older persons in the acute, subacute and resi-
dential care settings.
The specific review question to be addressed is: what
strategies/interventions are most effective in reducing the
incidence of medication incidents (errors) in the acute, sub-
acute and residential care settings?
Review method
An expert panel of 13 clinicians, nurses, pharmacists and
other allied health professionals was established to guide the
systematic review process by defining the criteria for study
inclusion, identification of key search terms and relevant
databases, and evaluating the clinical importance of the
resulting evidence (Appendix 1).
Criteria for considering studies for this review
Types of studies
This review considered any systematic reviews or ran-
domised controlled trials (RCTs) that evaluate strategies to
reduce or prevent medication incidents (Appendices II and
III). However, in the absence of any RCTs, other research
methods such as non-RCTs, longitudinal studies, cohort or
case–control studies, or descriptive studies were used. Qual-
itative studies, grounded theory and ethnographic studies
were included in a narrative summary. Only studies written
in the English language were included in the review. For the
purposes of the review, medication referred to medication
that has been prescribed by a medical practitioner, not over-
the-counter or herbal or vitamin preparations.
Types of participants
Those people who are involved in the prescribing, dispens-
ing or administering of medication to the older persons
(aged 65 years and older) in the acute, subacute or residen-
tial care settings were included in the review, namely:
• registered nurses;
• enrolled nurses (or equivalent, e.g. licensed practical
nurses);
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• pharmacists;
• physicians/medical practitioners (or equivalents); and
• personal care attendants/ancillary staff (or equivalent).
In the absence of articles relating the older persons spe-
cifically to medication incidents (errors) in the acute, sub-
acute or residential care settings, articles were reviewed that
did not specify the age of the client/patient, using the same
criteria as described previously.
Types of intervention
All studies reviewing strategies to prevent medication inci-
dents (errors) in the acute, subacute and residential settings
were considered.
Types of outcomes
The main outcome measure of interest to be considered was
the number of medication errors or adverse drug events
after intervention (and before in studies without parallel
control groups). In the absence of primary outcome mea-
sures, studies with surrogate measures such as test scores
and number of distractions were also considered.
Search strategy
The search terms in Table 3 were identified for a PubMed
search (Appendix IV). Similar terms and strategies were used
for the different bibliographic databases, with the same text
Table 3 PubMed search strategy management of medication
errors in older adults
Search category Search terms
MeSH Medication errors, aged, prescriptions, drug
Title or abstract
terms
Medication errors, adverse event, aged, 
elderly, adults, drugs, medication
Figure 1 Schema of the stages of searching and inclusion/exclusion of references for the review.
Initial search and assessment for inclusi 
(based on title and abstract) 
849 articles
56 articles retrieved and pearled for 
possible inclusions
Second assessment for inclusion 
(based on full text) 
6 additional articles identified and 
retrieved 
Final inclusion
20 studies, 3 
systematic reviews 
See Appendix II 
Excluded citations (775 articles):  
Wrong study design 
Wrong outcome(s) 
Wrong comparator 
Final exclusion 30 articles: 
Wrong study type 
Wrong outcomes
Identified in systematic review
8 other articles used in background
and one report describing types an 
causes of medication errors in 
Australia
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words being used along with the relevant alternatives to
MeSH (i.e. EmTree headings in EMBASE).
Bibliographic databases
• PubMed (NLM): 1986–February 2005
• Embase: 1986–February 2005
• CINAHL (SilverPlatter): 1986–February 2005
• Current Contents: 1993–February 2005
• Cochrane Library: 1986–February 2005
• Cochrane Database of Systematic Reviews (CDSR)
• Database of Abstracts of Reviews of Effectiveness
(DARE)
• The Cochrane Controlled Trials Register (CCTR)
• The Health Technology Assessment Database (HTA)
• NHS Economic Evaluation Database (NHS EED)
• Science Citation Index Expanded
• ProceedingsFirst: 1993–February 2005
• Social Science Index
• International Pharmaceuticals Abstracts
Health Technology Assessment (HTA) websites were also
searched for relevant systematic reviews and studies (see
Appendix V).
Search phases
The initial search was through the aforementioned elec-
tronic databases. Articles for inclusion were firsts assessed
from titles and abstracts only. Articles identified as potential
inclusions were collected and assessed for inclusion based
on the full text. The reference lists of all studies determined
to match the inclusion criteria for effectiveness or safety
were then pearled for any possible inclusions (Figure 1).
Methodological quality
The evidence presented in the selected studies was assessed
and classified using the dimensions of evidence defined by
the National Health and Medical Research Council.7
These dimensions (Table 4) consider important aspects of
the evidence supporting a particular intervention and
include three main domains: strength of the evidence, size
of the effect and relevance of the evidence. The first domain
is derived directly from the literature identified as informing
a particular intervention. The last two require expert clinical
input as part of their determination.
The three subdomains (level, quality and statistical
precision) are collectively a measure of the strength of the
evidence.
Level of evidence
Levels of evidence differ in terms of the hierarchy, depending
on the type of research question being asked. Studies assess-
ing the effectiveness of interventions were assessed using
the National Health and Medical Research Council levels of
evidence (Table 5).
Quality of evidence
The appraisal of systematic reviews was performed using a
checklist developed by the National Health Service Centre
for Reviews and Dissemination.8 This is a generic checklist
that allows for the appraisal of systematic reviews that incor-
porate study designs other than RCTs (Appendix VI). A ‘qual-
ity score’ will be approximated from this checklist by
attaching a point to each criterion that is met by the sys-
tematic review.
The appraisal of intervention studies was undertaken
using a checklist developed by the Joanna Briggs Institute
for Evidence Based Nursing and Midwifery.
A checklist of the quality of observational studies devel-
oped by the Joanna Briggs Institute for Evidence Based
Nursing and Midwifery was also used where appropriate
(Appendix VI).
Data collection and analysis
Study design and quality were tabulated and relative risks,
odds ratios, mean differences and associated 95% confi-
dence intervals were calculated from individual comparative
Table 4 Evidence dimensions
Type of evidence Definition
Strength of the evidence
Level The study design used, as an indicator of the degree to which bias has been eliminated by design
Quality The methods used by investigators to minimise bias within a study design
Statistical precision The P value or, alternatively, the precision of the estimate of the effect. It reflects the degree of 
certainty about the existence of a true effect
Size of effect The distance of the study estimate from the ‘null’ value and the inclusion of only clinically important 
effects in the confidence interval
Relevance of evidence The usefulness of the evidence in clinical practice, particularly the appropriateness of the outcome 
measures used
8 B Hodgkinson et al.
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studies containing count data where possible. All other data
were presented in a narrative summary.
Size of effect and relevance of evidence
For intervention studies, rank scoring methods were used to
determine the clinically important benefit of the effect size,
as well as the clinical relevance of the outcome being
assessed.7 A clinically important benefit will be set as a 20%
difference between the confidence limit closest to the mea-
sure of no effect and the no effect line (Appendix VI).
Results
Are interventions effective at reducing medication 
errors in older persons?
Are interventions that are designed to reduce medication
errors during the ordering, transcribing, dispensing and
administering of prescription drugs to patients 65 years and
over effective?
Three systematic reviews,6,8–10 one review4 and 20
studies11–30 were identified that attempted to answer this
question. One systematic review provided very general
information on the results of trials and therefore any stud-
ies not identified in the other reviews that addressed
interventions to reduce medication errors were individu-
ally identified and assessed10 and are included in the
count of the number of studies in the beginning of the
paragraph.
Before the discussion of the results of included studies,
several points should be highlighted. First, the majority of
studies did not direct interventions to patients in the older
persons category (≥65 years) but rather to patients within
their unit or hospital in general. Because of the paucity of
research specifically addressing the older persons, studies
that involved general patients were included. Second, the
definition of a medication error varied and the severity of
medication errors (i.e. life threatening vs. minor) was not
always reported.
Computerised systems
Analyses of medication errors have revealed that targeting
error prevention strategies at procedures and not individuals
is likely to be more effective.6 The following discussion
addresses the use of computer-based interventions at some
phase of the prescribing to administration pathway to
reduce medication errors.
Computerised physician ordering entry and clinical decision
support systems. Systems such as computerised physician
ordering entry (CPOE) and clinical decision support systems
(CDSS) were designed to target stages of ordering, and
administration and dispensing stages, respectively.
CPOE is described as a computer-based system whereby the
physician writes all orders online. Within this system the physi-
cian is provided with a menu of medications available from the
formulary displayed with the default doses and a list of the
potential range of doses. The system attempts to improve leg-
ibility, completeness and safety of orders.
CDSS provides computerised advice on drug doses, routes
and frequencies. CDSS can also perform drug allergy and
drug–drug interaction checks as well as prompt for corollary
orders (such as glucose levels after insulin has been
ordered).
A systematic review of studies evaluating CPOE and
CDSS in the reduction of adverse drug events and med-
ication errors was identified.9 Included study designs
consisted of RCTs, non-RCTs and observational studies
with controls. No patient group was specified. Defini-
tions of medication errors and adverse drug events as
defined in the systematic review are provided in the fol-
lowing box. 
Table 5 Designations of levels of evidence for assessing intervention studies
Level of evidence Study design
I Evidence obtained from a systematic review of all relevant randomised controlled trials
II Evidence obtained from at least one properly designed randomised controlled trial
III-1 Evidence obtained from well-designed pseudo-randomised controlled trials (alternate allocation or some other 
methods)
III-2 Evidence obtained from comparative studies (including systematic reviews of such studies) with concurrent 
controls and allocation not randomised, cohort studies, case–control studies or interrupted time series with 
a control group
III-3 Evidence obtained from comparative studies with historical control, two or more single-arm studies, or 
interrupted time series without a parallel control group
IV Evidence obtained from case series, either post-test or pre-test/post-test
Modified from National Health and Medical Research Council (2000).7
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Results were not combined in a meta-analysis but
provided as narrative summaries and are summarised as
follows.
Medication errors and adverse events. In two studies31,32
significant reductions in non-intercepted serious medication
errors (medication errors that either have the potential to or
actually cause harm to a patient) of 55% and 86% were
identified, with one study showing a 17% decrease in adverse
drug events; however, this was not significant.
Other outcomes. The remaining studies evaluated more
specific outcomes. A single study reported a significant
improvement in the rate corollary orders using computer-
ised reminders33 whereas another demonstrated an
improvement in five prescribing practices34 and a third study
identified a 13% and 24% decrease in inappropriate dose
and frequency, respectively, of nephrotoxic drugs in patients
with renal insufficiency.35
Three studies examined the effectiveness of computerised
advice for antibiotic dosing on adverse drug events, rates of
toxic drug levels or pathogen susceptibility.36–38 In a prospec-
tive before and after trial, use of CDSS was associated with
a 70% decrease in adverse drug events compared with
control, whereas an RCT found a 17% greater pathogen
susceptibility to the antibiotic drug regimen suggested by
CDSS.
In two RCTs evaluating CDSS guidance of theophylline
dosing, results between studies were contradictory.39,40 In
the larger of the two studies, the treatment group displayed
significantly lower rates of theophylline toxicity than the
control group. The smaller study found no such difference
and is likely underpowered.
Finally, two studies examining CDSS guidance of antico-
agulant dosing41,42 found no significant differences in bleed-
ing outcomes; however, given the small sample sizes, it is
likely that these studies are underpowered.
In a recent controlled trial, the effect of CPOE on medi-
cation errors was evaluated in a university hospital setting.30
After 8- and 11-month pre-intervention periods, two general
medicine units were provided with a CPOE system for a
further 7 and 4 months, respectively. During both pre- and
post-intervention periods, the number of reported medica-
tion errors was recorded. Other hospital units that continued
Medication error: errors in the process of ordering, prescribing,
dispensing, administering or monitoring medications.
Potential adverse drug events: medication errors with signifi-
cant potential to harm a patient that may or may not actually
reach a patient.
to use handwritten physician orders were also monitored for
medication errors and acted as control units.
Medication error was defined as an error in the process of
ordering, dispensing or administering a medication regardless
of whether the potential for injury was present.
Results showed that individually, the units receiving CPOE
systems showed no significant change in the number of
reported medication errors before and after the implemen-
tation of CPOE (Table 6). Pooled results of both units
showed an increase in the number of reported errors per
discharge. During the same period, control units displayed
a reduction in reported errors per discharge. Examination of
the stage at which errors occurred showed an increase in
reported error rates involving entry into the pharmacy com-
puter system (pharmacy order processing category) on units
using CPOE, but at no other stage.
Anecdotal evidence suggests that implementation of the
CPOE system in two US hospitals has reduced medication
errors by 37% and more than 50% since inception.43
Automated dispensing. A systematic review identified five
studies that examined the effectiveness of automated dis-
pensing systems on reducing medication error rates.6 This
review concluded that the available evidence was generally
poor and did not support the suggestion that automated
dispensing systems improved outcomes.
Not included in the Shojania review was a single study
that evaluated an automated point-of-use dose system
(Medstation Rx) in a 26-bed adult general medicine unit.28
Measurement of the incidence of dispensing error was
determined by comparing the technician error rate for filling
Medication errors and potential errors were voluntarily reported
on a form by nurses, pharmacists and physicians to the Univer-
sity’s Centre for Medication Safety. Each error was investigated
and the severity of the error was rated by medication safety team
member on a scale from 0 to 6 (no actual incident occurred;
potential error to incident resulted in death).
The system involves the location of controlled and secure med-
icine storage units at nursing stations with patient medication
profiles downloaded in the Pharmacy and transferred to the
appropriate nursing unit.
To dispense the desired medication the nurse selects the
patient of interest using the computer.
Nurse selects desired medication and the storage unit releases
the specific drawer and pocket containing the medication.
Drug inventory required in each storage unit determined
through historical usage data.
10 B Hodgkinson et al.
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storage units 6 weeks before and 6 weeks after the introduc-
tion of the Medstation Rx system.
Results are described in Table 7. The use of an automated
point-of-use dose system significantly reduced the rate of
error in filling of dosage carts by technicians.
Bedside terminal system. One study examined the effec-
tiveness of a portable bedside terminal documentation sys-
tem on nursing practice and medication error rate.14 A
medication error was defined as a variation from standard
practice and was to be recorded on an incidence report. 
Results are summarised in Table 8. The use of a bedside
terminal system had no effect on the reported medication
error rate.
In a 6-month study in three US hospitals in which full-
function clinical information systems were moved from nurs-
Bedside terminal systems involve the use of touch screen hand-
held portable terminals to enter and access data on individual
patients. These portable computers communicate via radio fre-
quency to a terminal server located on the unit.
Table 6 Effect of computerised physician ordering entry (CPOE) on the number of medication errors
Study Level of 
evidence
Quality Population Measure Results
Errors per discharge
Before After P
Spencer
et al.,
200530
III-3 QS 7/11 General medicine units Unit monitored
Before and after 
study
Clinical importance
not estimable
Unit 1 with CPOE 0.079 0.092 NS
Unit 2 with CPOE 0.06 0.083 NS
R not estimable Pooled CPOE 0.068 0.088 0.011
Control units 0.133 0.079 <0.001
Point of error†
Prescribing 0.014 0.008 NS
Unit order processing 0.014 0.018 NS
Pharmacy order processing 0.027 0.053 <0.01
Dispensing 0.003 0.001 NS
Delivery 0.005 0.002 NS
Administration 0.019 0.025 NS
Clinical monitoring 0.001 0.001 NS
†CPOE units only.
NS, not significant; P, probability; QS, quality score; R, relevance.
Table 7 Effectiveness of an automated point-of-use dose system
Study Level of evidence Quality Population Outcomes Results 
% of doses dispensed
Ray 
et al.,
199528
III-3
Before and after
study
QS 6/11
Clinical importance
2/4
Patients on a 26-bed
medical unit
Technician error
rate for filling
0.89% before implementation
0.61% after implementation
P = 0.04
R 3/5 Relative difference (95% CI): 
28.7% (3.6–53.8%)
CI, confidence interval; P, probability; QS, quality score; R, relevance.
Table 8 Effectiveness of a bedside terminal system (BTS)
Study Level of evidence Quality Population Outcomes Results
Brown
et al.,
199514
III-3
Before and 
after study
QS 7/11
Clinical importance
not estimable
R not estimable
Patients on a 35-bed
surgical unit
Medical error rate†
(40-h observation)
0.7/1000 before BTS
0.7/1000 after BTS
†Total number of medical errors/1000 doses dispensed.
QS, quality score; R, relevance.
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ing stations to the patient bedside, the authors claim a
reduction in medication errors of 34%.15
Computer-generated medication administration records.
One before and after study (Level III-3) in a 584-bed hospital
converted their handwritten 14-day medical administration
records (MAR) to a 24-h computer-generated MAR in an
attempt to increase the accuracy of medication administra-
tion, avoid discrepancies between the pharmacy and the
nursing staff and providing neat, legible documentation.11
The definition of a medication error was not defined in this
report.
The authors claim that a decrease in medication errors of
18% was obtained after the first year of the new protocol.
Computer alert system. Five studies were identified in a
systematic review that examined the use of computer alerts
to prevent adverse drug events.6 However, the evidence for
the effectiveness of such systems is weak. Only one study
demonstrated significant decreases in adverse drug events
using the alert system in a before and after study. One other
study found no significant benefit of an alert system on the
incidence of adverse drug events and three others only saw
improvements in the response times to obtaining laboratory
values. A final study demonstrated a significant change in
physician behaviour and their modification of patient therapy
based on the alerts and subsequent recommended actions.
One other uncontrolled trial evaluated the incorporation
of 37 adverse drug event alerts into the existing computerised
hospital information system of a 650-bed teaching hospital.27
An example of an adverse drug event alert was the following:
Primary prevention alert
Cardiac
Arrhythmia-digoxin – patient receiving digoxin and has a
serum potassium level <3.2 mmol/L, a serum magnesium
level <0.75 mmol/L or a digoxin level >2.5 nmol/L. Rec-
ommendation: electrolyte replacement or digoxin dose
reduction. 
The MAR is initially generated by order entry in the pharmacy.
The computer-generated MAR is then reconciled by the 11 PM
to 7 AM shift nurses. If a discrepancy exists, a variance report is
filled out and any corrections are made by the pharmacy.
Based on the patient information entered into the system, a
prescription could generate an adverse drug event alert that is
printed out and evaluated within the pharmacy. If necessary,
the alert is discussed with the appropriate nurse regarding
the patient’s clinical condition. The pharmacist may contact the
attending physician when the recommendations made by the
alert seem appropriate.
The study collected data on consecutive alerts for
6 months after inception of the program. A total of 9306
non-obstetrical patients flowed through the system with
1116 alerts recorded. Of these, 596 alerts (53%) were
deemed to be true positives requiring action. In 44% of
these true positives (265/596), the physician stated they
were unaware that a potentially dangerous clinical situation
existed.
Bar codes. A systematic review found one observational
study in which a hospital used hand-held scanners to iden-
tify the patient, nurse and the medication being adminis-
tered.6 The study found that the medication error rate in the
hospital decreased from 0.17% before the system was insti-
tuted to 0.05% after (P value not reported). Although this
result was encouraging, the use of the bar coding device
was ‘easily and frequently circumvented’, bringing into
question the real contribution of the device to the overall
error rate decrease.
In a recent ethnographic study nurse, physician and phar-
macist interaction with a newly instituted computerised sys-
tem of bar code medication administration (BCMA) was
observed in three veterans hospitals in the USA.26 The aim
of incorporating this technology was to reduce the inci-
dence of adverse drug events.  
Five negative themes (side-effects) were identified in this
study:
1 nurse confusion over automated removal of medications
by the BCMA;
2 degraded coordination between the nursing staff and the
physicians;
3 nurses dropped activities to reduce workload during busy
periods;
4 increased prioritisation of monitored activities during
busy periods; and
5 decreased ability to deviate from routine sequences.
One observer, trained in ethnographic field observations, con-
ducted all observations before and after the implementation of
BCMA. Observations occurred during all parts of day, evening
and night shifts for a duration of between 1 and 7 h.
BCMA involved the incorporation of software installed on a
laptop permanently attached to the wheeled medication chart.
Physicians were observed performing computerised order
entry followed by verification by the inpatient pharmacists.
Nurses scanned bar coded wristbands on individual patients
and ‘DUE’ medications would be indicated for that patient. The
medication bar code was then scanned and if it matched the
displayed information then the system recorded the medication
as given and recorded the time. If there was any discrepancy, a
pop-up alert was displayed.
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It was suggested that these observed side-effects might ‘cre-
ate new paths to adverse drug events’.
Therefore, the study authors recommended that the soft-
ware undergo design revisions and the hospitals institute
best practice training.  
Individual patient medication supply
Individual patient medication supply refers to the practice
of dispensing medications in a package that is ready to
administer to the patient. One systematic review6 and two
Australian studies44,45 were identified.
In the Australian studies,44,45 the use of individual patient
supply was found to significantly reduce the medication
error rate compared with a ward stock system of medication
supply with studies showing a decrease in the medication
error rate from 15.4% (76/494) to 4.8% (24/502)45 or
missed medications from 5.7% (223/3931 doses) to 4.1%
(136/3287 doses), respectively.44
In the systematic review,6 results suggested that there is a
positive impact of error reduction using an individual patient
supply system. Five studies met the review inclusion criteria
(four cross-sectional studies and one before and after study).
The majority of these studies reported reductions in medica-
tion errors using this system compared with alternative dis-
pensing methods such as the ward stock approach, primarily
in errors of omission and commission (erring in a task).  
General conclusions: computerised systems
Some evidence suggests that:
CPOE combined with CDSS may be effective in reducing
medication errors in a general hospital population.
Lower-level evidence for the effectiveness of:
Computer-generated MAR.
Computer adverse drug event detection and alerts.
No evidence to suggest that:
Automated dosing systems reduce medication error incidence.
Only reduce errors in filling of drawers by technicians.
The use of bedside terminal systems reduces medication error
incidence.
Bar coding patients or medications reduce medication error
incidence.
Education and training
One study examined the effect of a compulsory medication
examination on the rate of medication error in a 376-bed
community medical centre.24 
A medication error was defined as administering:
• the wrong medication;
• an extra dose;
• a medication to the wrong patient;
• a medication via the wrong route;
• a medication >30 min before or after the scheduled time;
• a medication from an expired order;
• an intravenous fluid at the wrong rate by >10%;
• or by omitting a medication.
Results showed no difference in the incidence of medica-
tion errors between the two time periods (Table 9).
One RCT evaluated the effectiveness of a 3-h educational
intervention compared with control (no education) on the
ability of nurses to calculate appropriate drug dosages.12
Errors in calculating medication dosages and flow rates were
assumed to be a surrogate outcome for medication errors.  
General conclusions: individual patient medication supply
Individual medication supply systems have been shown to
reduce medication error rates compared with other dispensing
systems such as ward stock approaches.
Unit dosages for each patient prepared in the pharmacy and
administered by registered nurses only.
During Phase I nurses were required to pass an annual
written medication examination consisting of 22 multiple-
choice and 12 matching questions and 5 dosage calculation
questions.
Phase II was instituted after policy was changed to eliminate
the annual examination as a requirement.
The study followed the number of reported medication errors
over a 6-month period for each phase.
Sixty-seven registered nurses were randomised into one of four
groups (three intervention, one control). Before intervention, all
participants completed a medication calculation test.
Medication calculation test included:
Table 9 Effectiveness of medication examination
Study Level of evidence Quality Population Outcomes Results
Ludwig Beymer
et al., 
199024
III-3
Before and after
study
QS 5/11
Clinical importance
not estimable
R not estimable
Community 
medical centre
patients
Incidence of medication
errors over a period of
6 months
With testing: 142
errors/6 months
Without testing: 137
errors/6 months
QS, quality score; R, relevance.
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Results showed an increase in post-test scores for all
groups (Table 10). However, analysis of covariance revealed
no significant difference in post-test medication calculation
test scores between any of the experimental groups and
controls (not shown). 
Pharmacists
A systematic review summarised the results of one system-
atic review and one RCT evaluating the role of clinical phar-
macists in preventing adverse drug events in outpatients,
and one systematic review and three other studies of
hospitalised patients.6 In the inpatient setting, this review
identified one prospective before and after study that dem-
onstrated a statistically significant 66% decrease in prevent-
able adverse drug events caused by medication ordering. In
a retrospective before and after study, the use of a clinical
pharmacist to check on new orders entering the pharmacy
resulted in a 40–50% overall reduction in medication errors.
In a meta-analysis of primarily controlled observational stud-
ies and non-randomised trials, the use of a pharmacist to
follow up with patients resulted in patients being more likely
to have a therapeutic peak and trough and less likely to have
a toxic peak and trough. In the outpatient setting, a system-
• 10 items on calculating oral dosages
• 4 items on intramuscular and subcutaneous dosages
• 6 items involving calculation of intravenous medication dosages
and flow rates
Intervention groups then underwent 3-h training via one of:
1 self-study workbook
2 computer-assisted instruction
3 group classroom instruction
Nurses re-tested 4–5 months after intervention.
General conclusions: education and training
There is no evidence to suggest that education addressing
medication calculation, or a yearly medication examination is
effective in reducing medication errors.
atic review of over 16 000 outpatients determined that the
use of a pharmacist for consultation, patient education and
follow-up resulted in improvements in outcomes for patients
with hypertension, hypercholesterolaemia, chronic heart
failure and diabetes. Other outpatient studies determined
that the use of pharmacist at discharge of geriatric patients
resulted in significantly fewer medication errors. Finally, in
an RCT of 181 patients with heart failure, patients in the
intervention group received clinical pharmacist evaluation,
which included medication evaluation, therapeutic recom-
mendations to the attending physician, patient education
and follow-up telemonitoring. The control group received
usual care. This study found all-cause mortality and heart
failure events were significantly lower in the intervention
group compared with the control group (4 vs. 16;
P = 0.005).
The involvement of a pharmacist at the point of prescrip-
tion (ordering) of a drug by the physician was evaluated by
three further studies.17,22,46 In two studies the pharmacist
either made rounds with the medical team to provide imme-
diate consultation22 or made rounds to each designated unit
every half hour to check on the accuracy of orders and to
provide consultation to the medical staff.46 The results of
these studies are summarised in Table 11.
Both studies displayed a decrease in the number of med-
ication errors per 1000 patient days with the improved
availability of a pharmacist for consultation. When the num-
ber of errors per number of patients in each study group
was examined, the use of a pharmacist with the rounding
team showed significant improvement compared with the
rounding team only.22
In a single study the process of reactive pharmacy inter-
vention was evaluated in a single-arm study.17 The objective
was, within the pharmacy, to identify prescriptions that may
have defects to prevent a possible impact on the patient (i.e.
an adverse event). 
Table 10 Effectiveness of 3-h education interventions
Study Level of 
evidence
Quality Population Outcomes Results
Pre-score Post-score
Mean SD Mean SD
Bayne and
Bindler,
199712
II QS 7/11
Clinical 
importance 3/4
67 registered
nurses
Medication test calculation scores
Group
Control (n = 18) 74.7 15.6 81.1 13.0
R not estimable Workbook (n = 18) 80.0 15.2 78.3 16.7
CAI (n = 14) 78.2 9.7 82.1 11.9
Classroom (n = 17) 70.3 17.5 78.8 17.1
CAI, computer-assisted instruction; QS, quality score; R, relevance; SD, standard deviation.
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Prescription considered by pharmacists
If prescription considered defective, the pharmacist recorded
the following:
• relevant drug details
• summary and categorisation of the problem
• coding of outcomes
• total time taken to initiate a response and resolve the
problem
• grade of the prescribing doctor
The potential for medical harm graded separately by a single
physician.
The study found that approximately 3% of prescriptions
written over the period of 28 days were flagged as faulty
(Table 12). A high proportion of interventions were consid-
ered justified (83%) during review, with 75% of interven-
tions resulting in altered prescriptions.  
General conclusions: pharmacists
There is some evidence to suggest a role for clinical pharma-
cists in preventing adverse drug events in the inpatient setting.
Table 11 Effect of pharmacist intervention on a number of medication errors
Study Level of evidence Quality Population Outcomes Results OR (95% CI)
Kucukarslan
et al., 
200322
III-2
Control 
study
QS 8/11
Clinical 
importance
Experimental group:
86 patients from 
general medical unit
Preventable 
ADE†
Rounding 
team plus 
pharmacist
Rounding 
team only
1/4 Mean age: No. of errors/1000 patient days
R 2/5 54 ± 19 years. 5.7 26.5 NA
Control: 79 patients
from general medical
No. of errors per population
of study group (%)
unit 2/86 (2.5) 9/79 (10) 0.19 (0.02, 0.94)
Mean age: 
56 ± 20 years
Shah et al.,
199446
III-3
Before 
and after 
study
QS 6/11
Clinical 
importance 
not estimable
R not 
estimable
303-bed acute care 
facility
Reported 
medication 
incidents 
(per 1000 
patient 
days)
Year before 
intervention
3.03
Year after
intervention
1.12
NA
†Preventable adverse drug event (ADE) defined as undesired reaction to medication that may have been prevented by appropriate drug selection or management.
CI, confidence interval; NA, not applicable; OR, odds ratio; QS, quality score; R, relevance.
Table 12 Effect of reactive pharmacy intervention on improvement in prescription quality
Study Level of 
evidence
Quality Population Outcomes Results 
Hawkey
et al.,
199017
IV
Prospective 
uncontrolled
study
NA All inpatients and 
outpatients in acute care,
mental illness, or elderly
Interventions in prescribing
process over a 28-day 
period, alterations to 
prescription, quality of 
the prescription
Intervention in 769 (2.9%) of 
all prescriptions over 28 days.
639 (83%) cases warranted 
intervention.
575 (75%) of intervention 
resulted in altered prescriptions
most notably because of:
• 280 wrong dosage
• 50 dosage not stated
• 48 over prolonged prescription.
In 246 interventions (32%),
alteration resulted in an
appreciable improvement in the
quality of the prescription
NA, not applicable.
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Nursing care models
Dedicated nurses. Three studies examined the effectiveness
of using dedicated nurses to dispense medication to
patients.14,16,25
In one RCT, 16 nurses from four nursing units of two
hospitals were designated to be either medication nurses,
administering medications to assigned patients, or general
nurses providing care in the ‘usual manner’.16 
The results of the study are presented in Table 13. This
study suggests that the use of dedicated medication nurses
does not reduce the incidence of total, medication and
process-variation error rates.
In a pilot project of before and after design (Level III-3)
involving four units in a 950-bed hospital, licensed practical
nurses were used as designated medication nurses.13 
The authors report that at the end of the trial the number
of reported medication errors was reduced to less than 50%
Medication nurses participated in a medication safety program
(1 day, 8 h).
Nurses were observed during medication administration
5 days a week (medication nurses for 2 days) for a period of
12 weeks.
Licensed practical nurses used as designated medication nurses
from Monday to Friday on the day and evening shifts.
Regular nursing staff provided medications on night shifts and
weekends.
The number of reported medication errors was evaluated
before trial and 3 months after inception.
of pre-trial levels in three of the units whereas a fourth
showed a 300% increase (4 reports to 12). The cause of this
apparent aberration was explained as low reporting pre-trial
and high staff turnover on this unit.
In a recent study, distractions during medication admin-
istration were used as a surrogate measure for the potential
for medication errors.25 The study of registered nurses in a
medical surgical unit during medication administration
‘cycles’ evaluated the use of two different interventions com-
pared with customary medication administration proce-
dures to reduce the number of distractions.  
Results of this study suggest that the use of a designated
nurse for medication administration can lead to a reduction
in the number of distractions that a nurse may encounter
during a medication administration cycle (Table 14). 
Medication administration cycle: encompasses commence-
ment of administration of all assigned patient medications
through to completion of documentation of all administered
medications.
Control: 8 cycles where nurses used customary medication
administration procedures (i.e. no designated nurse to deliver
medications).
Focused protocol: 8 cycles where a ‘special nurse’ designated
and staff asked not to interrupt or distract unless the interruption
is related to medications being administered.
Medsafe protocol: 8 cycles. Nurse required to wear a spe-
cial vest that identified nurse as performing medication
administration cycle and ‘Do Not Disturb’. Staff asked to
intercept all phone calls or other distractions during the
cycle.
Distractions were measured using a medication administra-
tion distraction observation sheet that was validated for this
study. The number of distractions per cycle was measured.
Table 13 Effectiveness of dedicated medication nurses
Study Level of 
evidence
Quality Population Outcomes Results P
Medication nurses General nurses
Greengold
et al., 
200316
II
RCT
QS 8/11
Clinical 
importance
not 
estimable
R 2/5
16 nurses ≥1 year of
acute care nursing.
Inpatients in 4 
units each of 1 
academic 
community 
hospital and 
1 university 
teaching hospital
Total error rates†
Medication error rates‡
Process variation 
error rates§
912/5792 (15.7)
651/5792 (11.2)
281/5792 (4.9)
545/3661 (14.9)
253/3661 (6.9)
306/3661 (8.4)
<0.84
<0.15
<0.06
†Total error rates = medication error rates + process variation error rates.
‡Medication error = wrong drug, dose, route, form, rate, dose preparation, administration technique or omission of drug.
§Process variation error = not checking patient wristband, borrowing medication, dosing from unlabelled dispenser (e.g. unlabelled syringe).
P, probability; QS, quality score; R, relevance; RCT, randomised controlled trial.
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Checking (single vs. double). Two Australian studies eval-
uated the effectiveness of single versus double checking of
medication by nurses for the reduction of medication
errors.20,21
In a single cross-over controlled trial in three wards of a
geriatric assessment and rehabilitation unit, the effectiveness
of two nurses versus one for reducing medication errors was
evaluated.21 
General conclusions: dedicated nurses
There is no evidence to suggest that providing designated
nurses to dispense medication significantly reduces the inci-
dence of medication errors.
Use of the focused or Medsafe protocols in which nurses are
identified as ‘not to be disturbed’ can reduce distractions to
nurses during medication administration.
Ward A selected for two-nurse medication administration for
23 weeks.
Ward B selected for one-nurse medication administration for
23 weeks.
Cross-over and:
Ward A selected for one-nurse medication administration for
23 weeks.
Ward B selected for two-nurse medication administration for
23 weeks.
Ward C selected for two-nurse medication administration for
whole period of study (control).
A medication error was defined as administering:
• a medication to the wrong patient;
• the wrong medication;
• an extra dose;
• a medication to patient with a known allergy to that
medication;
• a medication from an expired order;
• or by omitting a medication;
• or the medication chart not signed.
The results are summarised in Table 15. The point esti-
mate illustrates that the use of two nurses to administer
medications results in 30% lower odds of a medication error
being made compared with using one nurse.
In a lower-quality study (Level of evidence III-3), the
impact on nursing practice and the number of reported
medication errors were evaluated when standard practice of
double checking of medications before administration was
replaced with a single-checking protocol.20
Medication errors were identified by those reported on the
medication incident records over a period of 7 months for each
arm of the study (i.e. double and single checking).
Only five reported medication incidents were identified
over the 7-month period of standard practice (double
checking) compared with four reported incidents during
7 months of the single-checking protocol. This difference
was not significant and was suggestive that single checking
was as safe as double checking in this institution.  
Table 14 Effect of designated nurses on the number of distractions during medication cycles
Study Level of
evidence
Quality Population Study group Number of distraction during cycle
Mean
(of 8 cycles)
SD Mean difference (95% CI) P
Pape,
200325
III-2 QS 7/11 Registered
nurses
Control 60.5 12.9
Control
study
Clinical importance
not estimable
R 2/5
Focused protocol 22.5 8.5 38 (26.3, 49.7)† <0.001
Medsafe protocol 8.0 4.5 52.5 (42.1, 62.9)†
14.5 (7.2, 21.8)‡
<0.001
0.001
†Result compared with control.
‡Result comparing Medsafe protocol with focused protocol.
CI, confidence interval; P, probability; QS, quality score; R, relevance; SD, standard deviation.
Table 15 Effect of one or two nurses for medication administration
Study Level of evidence Quality Population Outcomes Results OR (95% CI) 
2 nurses 1 nurse
Kruse
et al.,
199221
III-1
Cross-over 
controlled trial
QS 8/11
Clinical 
importance 2/5
R 2/5
Geriatric 
patients
Errors/opportunities 92/43 428 120/40 275 0.7 (0.5, 0.9)
CI, confidence interval; OR, odds ratio; QS, quality score; R, relevance.
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Partners in patient care. This nursing practice model aims
to extend nurse time by introducing the use of nursing
partners. A single study that met inclusion criteria has exam-
ined the ‘partner in patient care’ (PIPC) model on nursing
units of a Florida hospital.19 A description of the model is
provided in a previous paper.23 
A medication error was determined by a single researcher as
any incident that deviated from standard procedure and was
clearly the responsibility of nursing.
Medication error rates ranged from 1/1000 to 4/1000
patient days; however, the comparison data from each study
group (control and pilot) were not provided. The study
found a significant difference in the medication error ratio
(errors/patient day, P = 0.008).  
Medication Administration Review and Safety. A before
and after study examined the effect of developing an inter-
disciplinary Medication Administration Review and Safety
(MARS) committee to reduce the number of medication
General conclusions: nurse double checking
There is some evidence to suggest that having two nurses
check medication orders before dispensing medication signifi-
cantly reduces the incidence of medication errors.
The PIPC nursing practice model involves five major compo-
nents:
1 Participation in decision-making by staff (staff involved in the
design of the practice model).
2 Use of a multiskilled technician in partnership with the nurse
as a patient care extender (nurse extender).
3 Education provided on the change process (three for-
mal classes).
4 Education on proper delegation of tasks to the nurse extender
(one class).
5 Bedside computers installed as a point of care system (in each
care room and at the central nursing station)
Pilot and control nursing units in a single hospital were randomly
selected:
Control units used a total patient care nursing model.
Pilot units implemented the new PIPC model.
Medication errors were derived from official incident reports.
Data were sampled at three time points, before the interven-
tion, 6 months into the implementation and at 1 year after
implementation.
General conclusions: PIPC
There is limited evidence to suggest that introducing the PIPC
model significantly reduces the incidence of medication errors.
administration documentation errors reported in a general
hospital.29 
A medication error was defined as mistake made during the
transcription, preparation, dispensation or distribution phases
of drug administration. Specifically, physician orders were
reviewed for accuracy of transcription and timeliness of imple-
mentation. Documented medications were reviewed for accu-
racy of right patient, medication, dose, route and time. Timely
administration of Stat, prn (as needed) and routine medications
was also evaluated.
Before the introduction of the MARS committee, medica-
tion administration documentation errors were reported a
frequency of 0.193 per patient day. One year after introduc-
tion of the MARS committee, the rate of errors had dropped
36.3% to 0.123 per patient day. 
Process change. One before and after study looked at the
effect a process change and education would have on the
ability of nurses to deliver insulin doses within a 60-min time
frame from point of blood glucose testing.18 Before imple-
mentation, the procedure for ordering and administering
insulin was not clearly defined or consistently followed.
Three nursing units were evaluated (a cardiac, thoracic and
neurosurgical ward, an orthopaedic ward and a cardiac pro-
gressive ward), for a period of 1 month before intervention
and 6 months after implementation of the changes. 
Control period before implementation involved present practice.
The hospital utilised a clinical information computer system
alongside an automated medication administration system.
MARS involved the introduction of an interdisciplinary com-
mittee of staff nurses, nurse managers, pharmacists, information
systems analysts, a risk manager and a nursing educator. This
committee reviewed all reported errors and then attempted to
identify potential causes of the errors. If necessary, medication
administration policies were revised. This information was then
shared with staff through a publication called a ‘Hot Spots’
brief.
A concurrent chart review analysed medication administration
documentation. Ten patients from each of every nursing unit
were audited for 7 days.
General conclusions: MARS
There is limited evidence to suggest that introducing MARS
committee can significantly reduce the incidence of medication
administration documentation errors.
Control: standard practice. This involved a physician filling out a
pre-printed insulin order form. A computerised MAR was gener-
ated by the pharmacist each evening to be used to record the
times of administration of insulin to each patient the following
18 B Hodgkinson et al.
© 2006 Blackwell Publishing Asia Pty Ltd
Data were analysed to determine the number of occasions
where insulin was administered within 60 min of blood glu-
cose determination, and the mean time between blood
day. The dose of insulin to be delivered was determined accord-
ing to a sliding scale based on a result from the patients blood
glucose test. No single method of blood glucose determination
was used by staff.
Treatment involved three changes to standard practice:
1 A nursing education program discussing the prevention of
insulin administration errors and the importance of the timing
between determination of a blood glucose and the subse-
quent administration of insulin to a patient.
2 Introduction of bedside blood glucose monitors to all units.
3 The computerised MAR was changed so that time and dose
of insulin were not recorded and therefore had to be recorded
by the nurse at time of administration.
All MAR records from 1 month were examined for the month
before the change and at 6 months after the implementation of
the quality improvement plan. Insulin dose was compared with
time of blood glucose time entered.
glucose determination and insulin delivery for four times
(breakfast, lunch, dinner and bedtime) for each unit. The
results for each unit and pooled results are shown in
Tables 16 and 17.
Overall, the number of cases that received insulin within
60 min of a blood glucose test improved significantly
(Table 16). However, individually this improvement was only
seen on Units 1 and 2. Examination of time periods in which
a significant reduction in time interval between time of
blood glucose test and insulin administration was seen at
breakfast, dinner and bedtime in Unit 1 but only at breakfast
in Unit 2 and lunch in Unit 3 (Table 17). 
General conclusions: process change for insulin administration
There is limited evidence to suggest that providing educa-
tion on diabetes management to nurses and the provision of
bedside blood glucose monitors can significantly reduce the
time between blood glucose measurement and insulin
administration.
Table 16 Number of cases receiving insulin within 1 h of blood glucose testing
Study Level of evidence Quality Population Unit Insulin delivered ≤60 min (%) OR (95% CI)
Control Treatment
Heatlie,
200318
III-3 QS 6/11 Nurses on 3 units 1 86/176 (48.9) 132/185 (71.4) 2.6 (1.7, 4.0)
Before and after
study
Clinical 
importance 1/4
2 142/190 (74.7) 163/192 (84.9) 1.9 (1.1, 3.2)
3 113/131 (86.3) 110/120 (91.7) 1.8 (0.8, 4.0)
R 2/5 Pooled 361/497 (72.6) 405/497 (81.5) 2.2 (1.6, 3.0)
CI, confidence interval; OR, odds ratio; QS, quality score; R, relevance; Unit 1, cardiac progressive; Unit 2, cardiac, thoracic and neurosurgical; Unit 3, orthopaedic.
Table 17 Time interval between blood glucose determination and insulin administration (min)
Study Level of evidence Quality Population Unit Time from blood glucose test to insulin 
delivery (min)
P
Control Treatment
n Mean ± SD n Mean ± SD
Heatlie,
200318
III-2
Control 
study
QS 7/11
Clinical 
importance 
1/4
R 2/5
Nurses on
3 units
1
Breakfast 26 125.5 ± 49.5 41 46.1 ± 23.0 0.00
Lunch 50 53.4 ± 28.4 50 56.9 ± 34.0 0.58
Dinner 50 70.0 ± 46.8 50 50.0 ± 31.9 0.01
Bedtime 50 60.7 ± 41.6 44 38.1 ± 32.6 0.01
2
Breakfast 40 52.4 ± 24.8 47 38.1 ± 20.8 0.01
Lunch 50 57.1 ± 29.0 50 46.7 ± 36.1 0.12
Dinner 50 55.6 ± 28.2 49 57.4 ± 37.7 0.79
Bedtime 50 37.2 ± 31.7 49 31.7 ± 23.8 0.33
3
Breakfast 24 56.4 ± 43.4 30 43.2 ± 37.8 0.24
Lunch 32 38.8 ± 21.5 30 27.1 ± 22.4 0.04
Dinner 49 45.1 ± 31.5 31 39.8 ± 25.8 0.44
Bedtime 26 30.6 ± 35.9 30 22.6 ± 33.7 0.39
P, probability (bold indicates significance); QS, quality score; R, relevance; SD, standard deviation; Unit 1, cardiac progressive; Unit 2, cardiac, thoracic and 
neurosurgical; Unit 3, orthopaedic.
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Quality of medication instruction to patients in the community
During the finalisation of this review, a single prospective
cohort study was identified concerning the quality of
instructions given to older adults taking warfarin, digoxin
and phenytoin when filling a prescription in the commu-
nity.47 Patients receiving these drugs were selected because
of the narrow therapeutic window of these medications and
the resulting higher risk of severe adverse events. This report
discusses only the baseline survey data from telephone inter-
views of over 4955 persons on the receipt of information
and quality of that information concerning their prescription
drugs at time of filling. The survey results suggested that
almost one-third of responders reported not receiving any
instruction on the use of these medications.
Discussion
The original goal of this systematic review was to evaluate
interventions to improve medication error incidence rates in
geriatric settings. However, it soon became apparent that
little research had been performed in strictly this environ-
ment. Persons aged 55 years and over account for a large
proportion of admitted patients and 49.6% of separations.48
Therefore, it was considered appropriate to include studies
from all clinical environments.
Types and causes of medication errors
Studies examining the types and causes of medication errors
occurring in older adults (≥65 years) are limited. However,
evidence is available on the general population and is taken
to be representative of those issues that would arise in the
geriatric setting.
Medication errors in the hospital setting have been stud-
ied extensively and the most common types of errors have
been identified generally as prescription/medication order-
ing errors, dispensing errors, errors in administration of
medicines and errors in the medication record. Specifically
these errors can most often be categorised as omissions
(>25%), overdoses (20%), wrong medicines (10%), drug of
addiction discrepancy (<5%), incorrect labelling (<5%) or
an adverse drug reaction (<5%). However, little is known as
to why medication errors occur in Australian hospitals. Fail-
ure to read, or misreading the chart, and a lack of robust
systems for prescribing and ordering were suggested as the
reasons for most of these errors.4
Based on limited Australian data on prescription errors,
approximately 2% of all prescriptions have the potential to
cause an adverse event with the most common causes being
the wrong or ambiguous dose, missing dose, or the direc-
tions for use were unclear or absent. This can be compared
with other countries in which the medication error rates
have been reported to be between 2% and 7%.6
Among the most common errors and their causes related
to medication that are encountered in community practice
(i.e. community pharmacies and general practices) are inap-
propriate drugs, prescribing errors, administration errors,
and inappropriate dose errors.4 The factors contributing to
these errors were forwarded by the doctors surveyed and
not from empirical evidence. Most commonly cited reasons
for medication errors in a community setting are poor com-
munication between patient and health professionals, action
of others (not GP or patient), error of judgement, poor
communication between health professionals, patient con-
sulted another medical officer and failure to recognise signs
and symptoms.
The most common types of dispensing errors reported by
pharmacists are the selection of the incorrect strength,
incorrect product or misinterpretation of a prescription. The
major reason for selecting the incorrect strength or product
has been described as the result of ‘look alike’ or ‘sound
alike’ error.
In an Australian survey of 209 community pharmacists,
the major factors cited for contributing to dispensing errors
were high prescription volume, overwork, fatigue, interrup-
tions to dispensing, ‘look alike, sound alike’ drug names.
Other factors that have been suggested as contributing
to medication errors are inadequate continuity of care
between the hospital and the community after discharge of
a patient, multiple healthcare providers where medicines
can be prescribed by more than one doctor, keeping unnec-
essary medications, generic names/trade names and misun-
derstanding the label instructions. However, the effect of
these factors on medication error and adverse drug events
has not been studied.
Effectiveness
Numerous interventions to reduce the incidence of medica-
tion errors were identified that evaluated all steps in the
pathway of delivery of medication to the patient. Included
in this review are evaluations of computerised ordering by
physicians, drug order checking by pharmacists, supply and
delivery of drugs to the respective medical units, and admin-
istration of drugs to the patients by nursing staff. Within
each step of the process, different types of interventions
were evaluated, such as the use of single versus double
checking by nurses before administration of a drug, or the
use of a dedicated nurse with a distinctive ‘jacket’ to identify
them as performing drug administration and not to be
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disturbed. Overall, however, for a number of the interven-
tions discussed in this review, the level of evidence was low
(small sample sizes, before and after studies) or the results
were poorly reported or inconclusive.
It was stressed in many of the researches reviewed here
that medication errors do not necessarily translate into
adverse drug events that could result in harm to patients. It
was apparent from this literature that once a definition of a
medication error was created the ease of determination of
an error was dependent primarily on the level of reporting
(i.e. the ease and willingness of clinicians to report an error).
However, the resulting effect of a medication error, if any,
on the patient was much harder to establish and therefore
many studies did not extend their outcomes to include this
eventuality.
In a number of studies, the number of reported medica-
tion errors was actually seen to increase after implementa-
tion of an intervention. This may have been the result of
increased vigilance and improved reporting systems rather
than an increase in the incidence of errors. Therefore, in
some studies it was impossible to accurately determine the
effectiveness of the specified intervention.
Computerised systems
Computerised systems consisted of a variety of interventions
including CPOE, automated dispensing, bedside terminals,
computer-generated MAR, alert systems and bar coding.
In summary, there was good evidence that CPOE system
combined with CDSS is effective in reducing medication
errors in a general hospital population.6 However, there
was lower-level evidence for the effectiveness of computer-
generated MAR, computer adverse drug event detection
and alerts. Finally, there was no evidence to suggest the
use of bedside terminal systems, or bar coding patients
or medications reduces medication error incidence, or
that automated dosing systems reduce medication error
incidence but only reduce errors in filling of drawers by
technicians.
The majority of the research was in the use of CPOE to
reduce medication errors and ultimately adverse drug
events. Although CPOE was shown to significantly decrease
the incidence of medication errors, it was noted that there
was little evidence for CPOE and/or CDSS reducing adverse
drug events and actual patient harm.6
A single report on the introduction of a computerised
MAR reported only that medication errors deceased from
one year to the next by 18%.11 It was assumed from the
report that medication errors were defined as a discrepancy
between the MAR and the pharmacy order, but this was not
implicitly stated. A positive of the new MAR was its readabil-
ity over handwritten documents.
The use of a computer alert system in one study showed
that in 44% of cases where the system alerted the physician
to a potential risk of an adverse drug event-related injury,
the physician was unaware of the risk.27 This suggests that
the system may be able to prevent a significant number of
potentially harmful medical errors. However, the system
consisted of only 37 drug-specific adverse drug events and
therefore would need to be expanded and updated to
encompass a greater variety of risk.
Providing bedside terminal systems in one community
hospital was evaluated for its effect on registered nurse time
spent in direct care activities, overtime, attitudes towards
the technology and unit medication error rate.14 No differ-
ence in unit error rates was noted. However, the study
duration for pre- and post-intervention observation was
short at 40 h each and the errors were counted from reports
on incident forms.
Identification of a single study in one systematic review6
found that nurse use of bar codes in a point of care infor-
mation system decreased the medication error rate in the
hospital from 0.17% before the system was instituted to
0.05% after (P value not reported). Although this result was
encouraging, the use of the bar coding device was ‘easily
and frequently circumvented’, bringing into question the
real contribution of the device to the overall error rate
decrease. The reasons for this were not described.
However, a recent ethnographic study of nurse, physician
and pharmacist interaction with a newly instituted comput-
erised system of BCMA identified five negative themes (side-
effects) that may elucidate the reason for the under-use of
the bar coding system reported in the review:26
1 nurse confusion over automated removal of medications
by the BCMA;
2 degraded coordination between the nursing staff and the
physicians;
3 nurses dropped activities to reduce workload during busy
periods;
4 increased prioritisation of monitored activities during
busy periods; and
5 decreased ability to deviate from routine sequences.
The available evidence from a systematic review for the
use of automated dispensing was found to be generally poor
and did not support the suggestion that automated dispens-
ing systems improved outcomes.6 In a single study the use
of an automated point-of-use dose system significantly
reduced the rate of error in filling of dosage carts by tech-
nicians only.28
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Individual patient medication supply
Individual medication supply systems have been shown to
reduce medication error rates compared with other dispens-
ing systems such as ward stock approaches. However, one
systematic review suggested that the use of these systems
shifts the chances for error from the nursing ward into the
pharmacy, where distractions are also common and errors
will occur.6
Education and training
Few studies were identified that examined the effectiveness
of nursing education or training programs on the prevention
of adverse drug events. From the two studies that were
included, there is no evidence to suggest that education
addressing medication calculation, or a yearly medication
examination is effective in reducing medication errors.12,24
Looked at another way, neither written medication exami-
nations nor education on medication calculation could
improve nurse competence to prevent errors beyond the
skills they had already accrued.
Pharmacists
There is good evidence to suggest a role for clinical phar-
macists in preventing adverse drug events in the inpatient
setting. From a systematic review, pharmacist intervention
in one study resulted in a 66% decrease in preventable
adverse drug events because of medical ordering and a
study of geriatric patients at the time of discharge found
statistically significant decreases in medication errors.6 The
value of the presence of a pharmacist during medication
rounds was also determined in two other studies.22,46 Both
studies displayed a decrease in the number of medication
errors per 1000 patient days with the improved availability
of a pharmacist for consultation.
Evidence for the effectiveness of pharmacists in reducing
adverse drug events in the outpatient setting is less
compelling.
Nursing care models
The strongest evidence suggests that having two nurses
check medication orders before dispensing medication sig-
nificantly reduces the incidence of medication errors.21 How-
ever, the authors question the clinical advantage of this
policy and do not recommend it. Weaker evidence sug-
gested that single checking could be as safe as double
checking, but was reliant on the number of medication
errors reported in the medication incident records and might
be a conservative estimate of the actual number of medica-
tion errors that actually occurred.20 It has been demon-
strated that actual error rate could be 33% higher than
reported rates.49
There is no evidence to suggest that providing designated
nurses to dispense medication significantly reduces the inci-
dence of medication errors.14,16,25 However, the use of the
focused or Medsafe protocols in which nurses are identified
as ‘not to be disturbed’ can reduce distractions to nurses
during medication administration.25 Distractions were used
as a surrogate measure of the potential for a medication
error. Although these strategies did not eliminate distrac-
tions during the medication ‘cycle’, these interventions were
shown to reduce them by as much as 87% compared with
customary medication rounds. The weakness of this study
may lie in the method of collection of distractions using a
previously unvalidated collection tool and the unavoidable
use of an unblinded observer.
Employment of a MARS committee was shown to have
a positive effect on reducing the number of medication
administration documentation errors over a period of
1 year.29 This is likely due to the heightened awareness of
medication error prevention and reporting.
There is limited evidence from one study to suggest that
introducing the PIPC model significantly reduces the inci-
dence of medication errors.23 This model was instituted in
an attempt to reduce the workload on registered nurses by
delegating less clinical tasks to a multiskilled technician.
Despite the claim that the PIPC model was effective at
significantly reducing the medication error ratio (errors/
patient day, P = 0.008), the data for before the institution
of the PIPC model and after were not presented and there-
fore could not be verified.
As an example of the implementation of process change
to improve the delivery of a specific drug and reduce the
likelihood of an adverse event, diabetes education to nurses
and the installation of blood glucose testing units in all
wards were assessed.18 Overall, the number of cases that
received insulin within 60 min of a blood glucose test
improved significantly. However, when individual units were
evaluated this improvement was not universal. Examination
of time periods in which a significant reduction in time
interval between time of blood glucose test and insulin
administration was seen at three time periods (breakfast,
dinner and bedtime) for one unit  but at only one time
period (breakfast or lunch) in the other two units. The unit
showing greatest improvement showed consistently higher
mean time intervals between blood glucose testing and
insulin delivery during the control phase of the study at all
measurement periods (means of 53–125 min) whereas the
mean times of the other units were all below 60 min.
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Recommendations
Implications for practice
Computerised systems
• CPOE should be considered as this strategy may reduce
the risk of misreading medication orders.
Individual patient medication supply
• Individual patient medical supply should be considered
for use wherever possible.
Pharmacists
• Where possible, pharmacists should be made available for
double checking medication orders and for consultation.
Nursing care models
• Double checking of medication orders by nurses before
administration of medicines can reduce the number of
medication errors.
• Identifying a dedicated nurse for medication administra-
tion may reduce the number of medication errors
through the reduction of distractions.
• The use of a MARS committee may have a positive effect
on reducing medication errors, likely because of the
heightened awareness of medication error prevention
and reporting.
Implications for research
More research is needed to determine:
• the effectiveness of MAR, bedside terminals, computer
alert systems and bar codes to reduce medication errors;
• the effectiveness of educational interventions to reduce
medication errors;
• whether the use of multiskilled technicians partnering
with nurses to reduce their workload (PIPC model) can
reduce the incidence of medication errors; and
• whether the use of dedicated nurses or double checking
can reduce the incidence of medication errors.
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Appendix I
Supporting committee for medication management
Associate Professor Susan Koch (Chair) ACEBAC Director, Collaboration
Professor Helen Baker (Professor of Nursing) Victoria University
Mr David Cooper Aged Care Standards & Accreditation Agency
Mrs Lisa Derndorfer (ACEBAC administrator)
Ms Cathie Edgar (Nurse Educator) Bundoora Extended Care Centre (BECC)
Mrs Mandy Heather (Director of Nursing) Bundoora Extended Care Centre (BECC)
Ms Susan Hunt, Nurse Consultant and Educator
Dr Kwang Lim (Geriatrician) Broadmeadows Health Service
Dr Michael Murray (Geriatrician) St George’s Health Service
Ms Karen O’Keefe (Director of Nursing) Caulfield General Medical Centre
Professor Kenn Raymond (Professor of Pharmacology) La Trobe University Bendigo
Mr Dipak Sanghvi (Pharmacist) The Pharmacy Guild of Australia
Dr Michael Whishaw (Geriatrician) Melbourne Extended Care and Rehabilitation Service
ACEBAC, Australian Centre for Evidence Based Aged Care.
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Appendix III
Studies excluded from the review
Appendix IV
Example search strategies
Search strategy for PubMed (contains MEDLINE and
pre-MEDLINE)
Study Reason for exclusion
Alemagno et al., 200450 Wrong outcome
Aufseeser Weiss and Ondeck, 
200151
Discussion paper
Ayuthya et al., 200352 Wrong outcome
Bates et al., 199831 Described in systematic review9
Bates et al., 199932 Described in systematic review9
Bolton et al., 200453 Wrong outcome
Boyle et al., 199844 Described in review4
Briggs, 200243 Discussion paper
Burton et al., 199137 Described in systematic review9
Casner et al., 199340 Described in systematic review9
Chertow et al., 200135 Described in systematic review9
Dhalla et al., 200254 No intervention
Dimant, 200155 No intervention
Evans et al., 199438 Described in systematic review9
Evans et al., 199836 Described in systematic review9
Hurley et al., 198639 Described in systematic review9
Larrabee et al., 199149 No intervention
McNally et al., 199745 Wrong outcome
Meredith et al., 200156 Wrong outcome
Mungall et al., 199442 Described in systematic review9
Mutter, 200357 Wrong outcome
Nelson, 200458 Descriptive, no intervention
Overhage et al., 199733 Described in systematic review9
Papastrat and Wallace, 200359 Wrong outcome
Roark, 200460 Discussion paper
Strohecker, 20035 Discussion paper
Teich et al., 200034 Described in systematic review9
Van den Bemt et al., 200261 Wrong outcome
Westwood et al.10 References assessed separately
White et al., 198741 Described in systematic review9
Whitman et al., 200262 Wrong outcome
Search
number
Search Number of
citations
#1 Search ‘medication errors’[MeSH Terms] 5 207
#2 Search ‘aged’[MeSH Terms] 1 431 569
#3 Search ‘prescriptions, drug’[MeSH Terms] 13 485
#4 Search ‘medication errors’[Title/Abstract] 1 050
#5 Search ‘aged’[Title/Abstract] 182 861
#6 Search ‘elderly’[Title/Abstract] 99 191
#7 Search ‘adults’[Title/Abstract] 154 948
#8 Search ‘drug’[Title/Abstract] 429 370
#9 Search ‘adverse event’[Title/Abstract] 3 891
#10 Search ‘medication’[Title/Abstract] 61 164
#11 Search (((#1)) OR (#4)) OR (#9) 9 306
#12 Search ((((#2)) OR (#5)) OR (#6)) OR (#7) 1 673 459
#13 Search (((#3)) OR (#8)) OR (#10) 486 510
#14 Search (((#11)) AND (#12)) AND (#13) 960
Appendix V
Health Technology Assessment (HTA) websites
Australia
• Australian Safety and Efficacy Register of New Interven-
tional Procedures – Surgical (ASERNIP-S) http://www.
surgeons.org/open/asernip-s.htm
• Centre for Clinical Effectiveness (Monash University, Aus-
tralia) http://www.med.monash.edu.au/healthservices/
cce/evidence/
• Health Economics Unit, Monash University http://
chpe.buseco.monash.edu.au
Austria
• Institute of Technology Assessment/HTA unit http://
www.oeaw.ac.at/ita/e1-3.htm
Canada
• Agence d’Evaluation des Technologies et des Modes
d’Intervention en Santé (AETMIS) http://www.aetmis.
gouv.qc.ca/en/index.htm
• Alberta Heritage Foundation for Medical Research
(AHFMR) http://www.ahfmr.ab.ca/publications.html
• Canadian Coordinating Office for Health Technology
Assessment (CCHOTA) http://www.ccohta.ca/newweb/
pubapp/pubs.asp
• Canadian Health Economics Research Association
(CHERA/ACRES) – Cabot database http://www.
mycabot.ca
• Centre for Health Economics and Policy Analysis (CHEPA),
McMaster University http://www.chepa.org
• Centre for Health Services and Policy Research (CHSPR),
University of British Columbia http://www.chspr.ubc.ca
• Health Utilities Index (HUI) http://www.fhs.mcmaster.ca/
hug/index.htm
• Institute for Clinical and Evaluative Studies (ICES) http://
www.ices.on.ca
Denmark
• Danish Institute for Health Technology Assessment
(DIHTA) http://www.dihta.dk/publikationer/index_uk.asp
Finland
• Finnish Office for Health Technology Assessment
(FINOHTA) http://www.stakes.fi/finohta/e/
France
• L’Agence Nationale d’Accréditation et d’Evaluation en
Santé (ANAES) http://www.anaes.fr/
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Germany
• German Institute for Medical Documentation and Infor-
mation (DIMDI)/HTA http://www.dahta.dimdi.de/
• German Scientific Working Group of Technology Assess-
ment http://www.epi.mh-hannover.de/(eng)/hta.html
The Netherlands
• Health Council of the Netherlands Gezondheidsraad
http://www.gr.nl/engels/welcome/frameset.htm
New Zealand
• New Zealand Health Technology Assessment (NZHTA)
http://nzhta.chmeds.ac.nz/
Norway
• Norwegian Centre for Health Technology Assessment
(SMM) http://www.oslo.sintef.no/smm/Publications/
Engsmdrag/FramesetPublications.htm
Spain
• Agencia de Evaluación de Tecnologias Sanitarias, Instituto
de Salud ‘Carlos III’I/Health Technology Assessment
Agency (AETS) http://www.isciii.es/aets/cdoc.htm
• Catalan Agency for Health Technology Assessment
(CAHTA) http://www.aatm.es/cgi-bin/frame.pl/ang/
pu.html
Sweden
• Swedish Council on Technology Assessment in Health
Care (SBU) http://www.sbu.se/admin/index.asp
Switzerland
• Swiss Network on Health Technology Assessment
(SNHTA) http://www.snhta.ch/
United Kingdom
• Health Technology Board for Scotland http://
www.htbs.org.uk/
• National Health Service Health Technology Assessment
(UK)/National Coordinating Centre for Health Technol-
ogy Assessment (NCCHTA) http://www.hta.nhsweb.
nhs.uk/
• University of York NHS Centre for Reviews and Dissemina-
tion (NHS CRD) http://www.york.ac.uk/Institute/crd/
• National Institute for Clinical Excellence (NICE) http://
www.nice.org.uk/index.htm
United States
• Agency for Healthcare Research and Quality (AHRQ) http:/
/www.ahrq.gov/clinic/techix.htm
• Harvard Center for Risk Analysis – Cost-Utility Analysis
Database Project (comprehensive league table) http://
www.hcra.harvard.edu/tablesdata.html
• US Department of Veterans Affairs Technology Assessment
Program (VATAP) http://www.va.gov/resdev/prt/
pubs_individual.cfm?webpage=pubs_ta_reports.htm
Appendix VI
Critical appraisal checklists
Systematic review critical appraisal checklist
Source: Khan et al., 20018
Title of assessment:
Title of systematic review:
Author(s):
Year:
Comparators:
Score: /6
1. What is the review’s objective?
What were the population/participants, interventions,
outcomes and study designs?
2. What sources were searched to identify primary studies?
What sources (e.g. databases) were searched and were
any restrictions by date, language and type of publication
used? Were other strategies used to identify research?
3. What were the inclusion criteria and how were they
applied?
4. What criteria were used to assess the quality of primary
studies and how were they applied?
5. How were the data extracted from the primary studies?
6. How were the data synthesised?
How were differences between studies investigated?
How were the data combined? Was it reasonable to com-
bine the studies?
What were the summary results of the review?
Do the conclusions flow from the evidence reviewed?
Rank scoring for appraising the clinical importance of benefit/
harm
Source: NHMRC, 20007
Title of review:
Title of study:
Author(s):
Year:
Comparators:
Clinically important effect:
38 B Hodgkinson et al.
© 2006 Blackwell Publishing Asia Pty Ltd
Rank Score:  /4
Rank scoring for classifying the relevance of evidence
Source: NHMRC, 20007
Title of review:
Title of study:
Ranking Clinical importance of benefit/harm
1 A clinically important benefit for the full range of 
plausible estimates.
The confidence limit closest to the measure of no effect 
(the ‘null’) rules out a clinically unimportant effect of the 
intervention.
2 The point estimate of effect is clinically important BUT 
the confidence interval includes clinically unimportant 
effects.
3 The confidence interval does not include any clinically 
important effects.
4 The range of estimates defined by the confidence interval 
includes clinically important effects BUT the range of 
estimates defined by the confidence interval is also 
compatible with no effect, or a harmful effect.
Author(s):
Year:
Comparators:
Rank Score:  /5
Checklist for appraising the quality of intervention studies
Ranking Relevance of the evidence
1 Evidence of an effect on patient-relevant clinical 
outcomes, including benefits and harms, and quality of 
life and survival.
2 Evidence of an effect on a surrogate outcome that has 
been shown to be predictive of patient-relevant 
outcomes for the same intervention.
3 Evidence of an effect on proven surrogate outcomes but 
for a different intervention.
4 Evidence of an effect on proven surrogate outcomes but 
for a different intervention and population.
5 Evidence confined to unproven surrogate outcomes.
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